PharmAust announced the first appointments to its veterinary clinical advisory board. Dr. Angela Frimberger and Dr. Christian Schirvel are international opinion leaders in the field of animal health and will advise and assist PharmAust on its veterinary cancer programme. Dr. Schirvel was previously Head of Business Development and Licensing (BD&L) at Elanco. Prior to this he served as Global Head BD&L (Therapeutics and Parasiticides) at Novartis Animal Health until it was acquired by Elanco. He was also Global Head of BD&L at Vétoquinol, and held several senior positions in Global Marketing and Strategic Development at Merial.